6 Hrs
Source:
الاقتصادية
Source: الاقتصادية
6 Hrsالاقتصادية
Source: الاقتصادية
6 HrsReady to play
Ready to play
AstraZeneca has acquired U.S.-based Omniose, a company specializing in the development of vaccines to combat serious bacterial infections, and integrated its business into its infectious diseases division. The financial terms of the deal were not disclosed. The acquisition followed three years of exclusive research collaboration between the two companies.
Notice: This Is an AI-Generated Summary
Comments (0)